抗抑郁药及其临床应用的研究进展

被引:14
作者
李焕德
朱运贵
易清华
机构
[1] 湖南医科大学附属第二医院!长沙,湖南医科大学附属第二医院!长沙,株州市化工厂职工医院
关键词
抑郁剂; 抑郁症; 药物疗法; 受体;
D O I
10.13220/j.cnki.jipr.1998.04.010
中图分类号
R971.43 [];
学科分类号
1007 ;
摘要
对近年来国外的抗抑郁药开发和临床应用研究进行了综述 ,分别叙述了各种抗抑郁药的作用机理、药代动力学参数、临床应用和不良反应 ,介绍了与抑郁症治疗有关的临床药理学、遗传药理学 ,并展望了抗抑郁剂的开发和临床应用。
引用
收藏
页码:228 / 232
页数:5
相关论文
共 17 条
[1]  
Comparison of the tolerability ofbupropion,fluoxetine,imipramine,nefazodone,paroxetine,sertraline,and venlafaxine. Preskorn SH. Journal of Clinical Psychopharmacology . 1995
[2]  
Venlafaxine:tolerance and safety. Magni G. Journal of Clinical Psychiatry . 1993
[3]  
Pharmacology and neurochemistry of nefazodone,a novel antidepressant drug. Taylor DP,Carter RB,Eison AS,et al. Journal of Clinical Psychiatry . 1995
[4]  
The role of venlafaxine in rationalantidepressant therapy. Feighner JP. Journal of Clinical Psychiatry . 1994
[5]  
Clinical overview ofserotonin reuptake inhibitors. Rickels K,Schweizer E. Journal of Clinical Psychiatry . 1990
[6]  
Fluoxetine- induced tricyclictoxicity:extent and duration. Westermeyer J. Journal of Clinical Pharmacology . 1991
[7]  
Bupropion:a review of itsmechanism of antidepressant activity. Ascher JA,Cole JO. Journal of Clinical Psychopharmacology . 1995
[8]  
Inc-reased carbamazepine plasma concentrations afterfluoxetine coadministration. Grimsley SR,Jann MW,Carter JG,et al. Clinical Pharmacology and Therapeutics . 1991
[9]  
Antidepressant drug selection:criteria and options. Preskorn SH. Journal of Clinical Psychiatry . 1994
[10]  
Serotonergicmechanisms and current and future psychiatricpractice. Dubovsky SL,Thomas M. Journal of Clinical Psychiatry . 1995